Name
ORAL ABSTRACT: Efficacy by baseline characteristics in the phase 3 LITESPARK-005 study of belzutifan versus everolimus for previously treated advanced clear-cell renal-cell carcinoma (ccRCC)
Date & Time
Friday, April 19, 2024, 12:59 PM - 1:09 PM
Speakers
Laurence Albiges, Gustave Roussy
Laurence Albiges
Description

Laurence Albiges, MD, PhD, Institut Gustave Roussy

Presentation Slides

Location Name
Auditorium
Full Address
Melia Sitges Hotel
Calle Joan Salvat Papasseit 38
Sitges Spain 08870
Spain